By Philip T. Powell, Indiana University Kelley School of Business associate dean of academic programs in Indianapolis and clinical associate professor of business economics and public policy When fighter pilots bank their jet for a steep climb, gravity exerted upon the human body suddenly multiplies. “Feeling the G’s” causes disorientation. This best describes what the 2021 economic… Read more »
Faculty
IU student, alumni startups receive $220,000 from Elevate Nexus Pitch Competition
Five startups with connections to Indiana University students or alumni received $220,000 in total during the fall 2020 Elevate Nexus Pitch Competition. Deep Word and ShuffleMe both received $20,000 in the pre-seed category for the Southern Indiana region. Reezy received $20,000 in the pre-seed category for the Central Indiana region. Blueprint Stats and Stagetime Inc…. Read more »
Assembly Biosciences and Door Pharmaceuticals sign collaboration and option agreement
Assembly Biosciences Inc. (Nasdaq: ASMB) and Door Pharmaceuticals LLC have announced that the companies have signed an exclusive, two-year collaboration and option agreement focused on the development of a novel class of hepatitis B virus core protein modulators. Door Pharmaceuticals’ innovative discovery platform targets functions of core protein that are distinct from viral assembly and… Read more »
Esteemed panelists to discuss IU’s support of innovation, commercialization Oct. 29
Innovative researchers and entrepreneurs with Indiana University connections will speak Oct. 29 about factors critical to their success and how the university can support faculty and students with interests in innovation and commercialization. The panel will include Richard DiMarchi and Jack Gill, who will receive the first-ever Wylie Innovation Catalyst Medals in a presentation preceding… Read more »
Kelley School’s 2021 Business Outlook forecast being presented virtually statewide beginning Nov. 9
Presentations will cover 10 Indiana urban areas; nearly all are free to the public By George Vlahakis, Kelley School of Business The Indiana University Kelley School of Business will present its 2021 economic forecasts for the nation, financial markets, Indiana and communities across the state through a series of live and mostly free presentations delivered… Read more »
IU ICO reports on 2019-20 fiscal year milestones
The 2019-20 fiscal year was a strong one for the Indiana University Innovation and Commercialization Office, said Simran Trana, IU associate vice president of innovation and commercialization. “This was an unusual year, and not only because of the impact of the novel coronavirus,” Trana said. “IU researchers quickly pivoted their work to create new methods… Read more »
These 64 IU researchers were named on issued patents in 2019-20
The Indiana University Innovation and Commercialization Office again reported a strong year in technology transfer activity. It received 157 patents from the U.S. Patent and Trademark Office and foreign patent organizations during the 2019-20 fiscal year. Sixty-four current IU researchers were named on the patents. They are: IU Bloomington Andrew Alexander Lane Baker Yves Brun… Read more »
IU delivers $9.9 billion impact on state, high return on investment for students and taxpayers
Indiana University added $9.9 billion in income to Indiana’s economy in FY 2018-19 through its investments in the educational success of its students; research and innovation; and engagement in the economic development, health and well-being of Hoosier communities across the state. Expressed in terms of employment, IU’s impact supported 151,015 jobs, according to the results… Read more »
Kelley joins IU Ventures Investment Committee
Mark R. Kelley is the newest member of the IU Ventures Investment Committee. Kelley, a professor of pediatrics and cancer researcher at Indiana University School of Medicine, was appointed by Jay L. Hess, dean of IU School of Medicine and an IU Ventures board member. Kelley succeeds Distinguished Professor Emeritus Mervin Yoder, who served on the committee from 2014 to… Read more »
Another example of IU expertise at innovation and commercialization
By Samantha Ginther, senior associate, IU Ventures Everyone at the Indiana University Innovation and Commercialization Office and IU Ventures congratulates drug discovery company MBX Biosciences for recently completing a $34.6 million Series A round of funding. This is the latest entrepreneurial good news for Indiana University researcher and Distinguished Professor Richard DiMarchi, IUPUI alumnus Kent… Read more »